Observational Study of Docetaxel Exposure in Metastatic Prostate Cancer Patients
Public ClinicalTrials.gov record NCT02376296. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Observational Study of Metastatic Prostate Cancer Subjects Receiving Docetaxel Therapy for Evaluation of Docetaxel Plasma Levels Using the MyDocetaxel Assay
Study identification
- NCT ID
- NCT02376296
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Saladax Biomedical, Inc.
- Industry
- Enrollment
- 35 participants
Conditions and interventions
Conditions
Interventions
- docetaxel Drug
- Blood draws Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2015
- Primary completion
- Feb 9, 2018
- Completion
- Feb 9, 2018
- Last update posted
- Feb 16, 2022
2015 – 2018
United States locations
- U.S. sites
- 20
- U.S. states
- 1
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UPMC CancerCenter - Beaver | Beaver | Pennsylvania | 15009 | — |
| UPMC CancerCenter - Upper St. Clair | Bethel Park | Pennsylvania | 15102 | — |
| UPMC CancerCenter - Horizon | Farrell | Pennsylvania | 16121 | — |
| Arnold Palmer Cancer Center - Oakbrook | Greensburg | Pennsylvania | 15601 | — |
| Arnold Palmer Cancer Center | Greensburg | Pennsylvania | 15601 | — |
| UPMC CancerCenter - Greenville | Greenville | Pennsylvania | 16125 | — |
| UPMC CancerCenter - Indiana | Indiana | Pennsylvania | 15701 | — |
| UPMC CancerCenter at John P. Murtha Regional Cancer Center | Johnstown | Pennsylvania | 15901 | — |
| UPMC CancerCenter - Mckeesport | McKeesport | Pennsylvania | 15132 | — |
| UPMC CancerCenter - Monroeville | Monroeville | Pennsylvania | 15146 | — |
| Arnold Palmer Medical Oncology - Mount Pleasant | Mount Pleasant | Pennsylvania | 15666 | — |
| UPMC CancerCenter - New Castle | New Castle | Pennsylvania | 16105 | — |
| UPMC CancerCenter - St. Margaret | Pittsburgh | Pennsylvania | 15215 | — |
| UPMC CancerCenter - Hillman Cancer Center | Pittsburgh | Pennsylvania | 15232 | — |
| UPMC CancerCenter - Passavant HOA | Pittsburgh | Pennsylvania | 15237 | — |
| UPMC CancerCenter - Passavant OHA | Pittsburgh | Pennsylvania | 15237 | — |
| UPMC CancerCenter - Northwest | Seneca | Pennsylvania | 16346 | — |
| UPMC CancerCenter - Uniontown | Uniontown | Pennsylvania | 15401 | — |
| UPMC CancerCenter - Washington | Washington | Pennsylvania | 15301 | — |
| UPMC CancerCenter - Jefferson | West Mifflin | Pennsylvania | 15122 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02376296, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 16, 2022 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02376296 live on ClinicalTrials.gov.